Treatment for wet age-related macular degeneration has advanced significantly with anti-VEGF therapies, but the need for frequent injections remains a challenge. A new, longer-lasting treatment now in development aims to reduce treatment burden while helping preserve vision. This podcast was produced for Ocular Therapeutix by Scientific American Custom Media, a division separate from the magazine’s board of editors. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Science Quickly
You’re probably walking past edible plants every day
Can you spot a romance scam?
Navigating Science and Health Misinformation [Sponsored]
Fire amoebas, fossilized vomit and AI energy demands
Get summaries like this every morning.
Free AI-powered recaps of Science Quickly and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.